TruGraf Long-term Clinical Outcomes Study

Brief description of study

The purpose of this study is to evaluate post-transplant clinical outcomes in recipients of kidney transplants who are undergoing TruGraf® and TRAC monitoring. These tests are commercially available blood tests that may help better monitor rejection. Targeted population are kidney transplant recipients. Procedures include blood will be drawn for TruGraf® and TRAC testing during the first visit and every 3 months after for a period of 2 years.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Kidney Transplant Rejection
Age: Between 18 Years - 99 Years
Gender: All

Male or Female, Age 18 or older kidney transplant patients who are at least one year from the time of transplant

Updated on 09 Mar 2024. Study ID: 844616

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).